Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation.

For recurrence-free survival, the HR for positive cross-match results for B cells at 37°C was 2.58 (95% CI: 0.98-6.78; borderline significance) and that for positive cross-match results for T cells at 4°C was 3.35 (95% CI: 1.08-10.40).

also in 7,017 other papers

The positive group exhibited a higher incidence of prior hepatectomy and a poorer tumor status (beyond Milan, microvascular invasion, and AFP > 400 ng/mL) than did the negative group, although the differences did not reach statistical significance.

also in 111,027 other papers